Eidos Therapeutics, Inc.
Pharmaceutical company · San Francisco, California, United States
Eidos Therapeutics, Inc. is a pharmaceutical company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2013. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2018.
Eidos Therapeutics at a glance
What does Eidos Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $26 million sold (2018).
Frequently asked questions about Eidos Therapeutics
Where is Eidos Therapeutics headquartered?
Eidos Therapeutics, Inc. is headquartered in San Francisco, California, United States.
What does Eidos Therapeutics do?
Eidos Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Eidos Therapeutics founded?
The earliest incorporation on record for Eidos Therapeutics, Inc. is in 2013, according to public company registers.
Similar companies
- Kyntra Bio, Inc.San Francisco, California, United States
- Nektar TherapeuticsSan Francisco, California, United States
- Olema Pharmaceuticals, Inc.San Francisco, California, United States
- GT Biopharma, Inc.San Francisco, California, United States
- Delpor, Inc.San Francisco, California, United States
- Jaguar Health, Inc.San Francisco, California, United States
- Silver Creek Pharmaceuticals, Inc.San Francisco, California, United States
- Amarantus Bioscience Holdings, Inc.San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences